Get Free Delivery With No Minimum Order

BABY TWIST D3 400 IU 100 CAP
- Sku : I-027605
Key features
BABY TWIST D3 400 IU 100 CAP is a soft-capsule vitamin supplement providing cholecalciferol (Vitamin D3) at 400 IU (12.5 mcg) per capsule. It supports healthy bone and teeth development, immune function, and calcium absorption in infants and children. Formulated as cholecalciferol-the most bioavailable form of vitamin D-it is approximately 87% more effective than ergocalciferol (D2) at raising and sustaining serum 25‑hydroxyvitamin D levels. Supplied in a 100-capsule pack with a serving size of one soft capsule.- Brand: BABY TWIST
- Supplement Type: Vitamin
- Active Compounds: Cholecalciferol (Vitamin D3) 400 IU (12.5 mcg) per soft capsule
- Supplement Form: capsule, soft
- Serving Size: 1 soft capsule
- Servings Per Container: 100
- Pack Size: 100 Capsules
- Primary Benefit: Supports healthy bone and teeth development, immune function, and calcium absorption in infants and children.
- Bioavailability Form: Cholecalciferol (Vitamin D3) - the most bioavailable form of vitamin D, 87% more effective than ergocalciferol (D2) at raising and sustaining serum 25-hydroxyvitamin D levels.
- Prescription Status: OTC
- Certification: SFDA registered (Registration No. 1709200155); manufactured under GMP by Jamjoom Pharmaceuticals Factory Company, Saudi Arabia.
- Manufacturer: Jamjoom Pharmaceuticals Factory Company
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 1709200155
- Shelf Life: 24 months
- Age Range: 0-6 months
- Flavor: Unflavored
Benefits & Uses
Primary Benefit
Supports healthy bone and teeth development, immune function, and calcium absorption in infants and children.
Health Claims
Supports normal bone and teeth development; contributes to normal calcium and phosphorus absorption; supports immune system function; reduces risk of rickets in vitamin D-deficient infants and children.
Common Deficiency Symptoms
Rickets in infants and children, delayed tooth eruption, bone pain, muscle weakness, frequent respiratory infections, irritability, and poor growth.
Target Population
Infants and young children, exclusively or partially breastfed infants, children with limited sun exposure, dark-skinned children, and children in regions with low sunlight exposure.
Scientific Evidence Level
Strong
Onset Timeline
Serum 25-hydroxyvitamin D levels begin to increase within 2-4 weeks of consistent supplementation; bone density improvements and rickets prevention effects are observed over 3-6 months.
Usage & Dosage
Suggested Use
Twist off the tail of the capsule and squeeze the liquid contents directly into the infant's mouth or mix with a small amount of milk or food. Take 1 soft capsule daily.
Serving Size
1 soft capsule
Servings Per Container
100
Best Time to Take
With meals
Recommended Daily Intake
Infants 0-12 months: 400 IU/day (10 mcg); Children 1-13 years: 600 IU/day (15 mcg).
Upper Tolerable Limit
Infants 0-6 months: 1000 IU/day (25 mcg); Infants 7-12 months: 1500 IU/day (37.5 mcg); Children 1-3 years: 2500 IU/day; Children 4-8 years: 3000 IU/day; Children 9-18 years: 4000 IU/day.
Absorption Enhancers
Dietary fat (co-administration with fat-containing meals such as breast milk or formula significantly increases absorption); magnesium supports vitamin D activation and metabolism.
Absorption Inhibitors
Orlistat and cholestyramine reduce vitamin D absorption; mineral oil interferes with fat-soluble vitamin absorption; anticonvulsants (phenytoin, phenobarbital) accelerate vitamin D catabolism.
Side Effects
Possible Side Effects
Generally well-tolerated at recommended doses (400 IU/day). Excessive intake may cause hypercalcemia, presenting as nausea, vomiting, constipation, polyuria, poor appetite, and weakness.
Toxicity Risk
Low
Upper Tolerable Limit
Infants 0-6 months: 1000 IU/day (25 mcg); Infants 7-12 months: 1500 IU/day (37.5 mcg); Children 1-3 years: 2500 IU/day; Children 4-8 years: 3000 IU/day; Children 9-18 years: 4000 IU/day.
Safety & Warnings
Contraindications
Hypercalcemia, hypervitaminosis D (vitamin D toxicity), hypersensitivity to cholecalciferol or excipients, severe renal impairment, nephrolithiasis.
Pregnancy Safety
Consult Doctor
Breastfeeding Safety
Safe
Children Suitability
Suitable for infants and children from birth onward; designed for pediatric use at 400 IU/day prophylactic dose.
Interactions
Medication Interactions
Orlistat reduces vitamin D absorption; thiazide diuretics combined with vitamin D may increase risk of hypercalcemia; corticosteroids reduce vitamin D efficacy; anticonvulsants (phenytoin, phenobarbital) accelerate vitamin D metabolism.
Supplement Interactions
High-dose calcium supplements combined with vitamin D may increase hypercalcemia risk; excessive vitamin A intake may antagonize vitamin D activity.
Synergistic Nutrients
Calcium and phosphorus (bone mineralization); Vitamin K2 (directs calcium to bones and away from soft tissues); Magnesium (activates vitamin D metabolism and conversion).
Special Populations
Target Population
Infants and young children, exclusively or partially breastfed infants, children with limited sun exposure, dark-skinned children, and children in regions with low sunlight exposure.
Children Suitability
Suitable for infants and children from birth onward; designed for pediatric use at 400 IU/day prophylactic dose.
Pregnancy Safety
Consult Doctor
Breastfeeding Safety
Safe
Storage & Patient Advice
SFDA Storage Conditions
do not store above 25°c
Storage Conditions
Store below 25°C in a cool, dry place. Keep away from direct sunlight and out of reach of children. Shelf life: 24 months.
Patient Counseling
Administer 1 soft capsule (400 IU / 12.5 mcg cholecalciferol) once daily. For infants, twist off the capsule tail and squeeze contents directly into the mouth or mix with a small amount of breast milk or formula. Administer with a fat-containing meal to maximize absorption. Breastfed infants routinely require vitamin D supplementation as breast milk contains insufficient amounts. Do not exceed age-appropriate upper tolerable limits without medical supervision. Consult a physician before use in children with hypercalcemia, hypervitaminosis D, significant renal disease, or a history of kidney stones. Store below 25°C and keep out of reach of children.
Science & Evidence
Bioavailability Form
Cholecalciferol (Vitamin D3) - the most bioavailable form of vitamin D, 87% more effective than ergocalciferol (D2) at raising and sustaining serum 25-hydroxyvitamin D levels.
Water or Fat Soluble
Fat-soluble
Scientific Evidence Level
Strong
Onset Timeline
Serum 25-hydroxyvitamin D levels begin to increase within 2-4 weeks of consistent supplementation; bone density improvements and rickets prevention effects are observed over 3-6 months.
Food Sources
Fatty fish (salmon, sardines, mackerel), cod liver oil, egg yolks, fortified infant formula, fortified cow's milk, UV-exposed mushrooms.
Product Information
Supplement Type
Vitamin
Allergen Info
Contains gelatin (soft capsule shell, likely bovine or porcine origin); free from gluten and soy.
Certification
SFDA registered (Registration No. 1709200155); manufactured under GMP by Jamjoom Pharmaceuticals Factory Company, Saudi Arabia.
Suitable for Vegetarians
No
Suitable for Vegans
No (derived from lanolin)
Age Range
0-6 months
Flavor
Unflavored
-1744229570.gif)

